Vesigard 7.5 Tablet PR
Marketer
Cipla Ltd
Salt Composition
Darifenacin (7.5mg)
Overview Vesigard 7.5 Tablet PR
Tolterodine 7.5mg extended-release tablets are an anticholinergic medication employed to manage overactive bladder syndrome. This treatment alleviates bothersome urinary symptoms such as urinary frequency, urgency, and incontinence. Always adhere to your physician's prescribed dosage and regimen. This medication may be ingested with or without food. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may exacerbate symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal therapeutic benefit. Potential side effects include constipation, headache, dry mouth, urinary tract infections, nausea, and dry nasal passages. Report any persistent or troublesome side effects to your doctor promptly; they can offer strategies for mitigation. Prior to commencing treatment, disclose all current medications and any existing health conditions. Inform your doctor if you are pregnant or breastfeeding. This medication is contraindicated in patients with severe hepatic impairment; seek medical counsel before use.
Primary Ingredients of Vesigard 7.5 Tablet PR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vesigard 7.5 Tablet PR
Managing the signs and symptoms of overactive bladder
Major Benefits of Vesigard 7.5 Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Vesigard 7.5mg tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Vesigard 7.5 Tablet PR:
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use Vesigard 7.5 Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Vesigard 7.5 Tablet PR can be administered with or without food; however, consistent daily timing is recommended.
How Vesigard 7.5 Tablet PR works:
Vesigard 7.5 mg prolonged-release tablets contain an antimuscarinic agent that reduces bladder muscle spasms, thus alleviating symptoms of frequent, urgent, or involuntary urination.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vesigard 7.5 Tablet PR may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Vesigard 7.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Vesigard 7.5 Tablet PR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Vesigard 7.5 Tablet PR, a medication that can induce side effects like dizziness, blurred vision, insomnia, or drowsiness.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Vesigard 7.5 Tablet PR is considered safe, and no dosage modification is typically necessary. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vesigard 7.5 mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Vesigard 7.5 Tablet PR :
Should you forget to take a Vesigard 7.5 Tablet PR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Vesigard 7.5 Tablet PR
| Label | Value |
|---|---|
| Chemical Category | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |



